Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.005
-0.055 (-5.19%)
At close: Aug 1, 2025, 4:00 PM
1.000
-0.005 (-0.50%)
After-hours: Aug 1, 2025, 6:16 PM EDT
Exscientia Market Cap
Dyadic International has a market cap or net worth of $30.29 million as of August 1, 2025. Its market cap has decreased by -27.54% in one year.
Market Cap
30.29M
Enterprise Value
28.00M
1-Year Change
-27.54%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $30.29M, a decrease of -68.05%. That is a compound annual growth rate of -16.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 30.20M | -41.70% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |